Drug Name: Jesduvroq
Indications: To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months.
Active Ingredient: Daprodustat
Company: GlaxoSmithKline
Approval Date: 2/1/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf